Ignite Creation Date:
2025-12-24 @ 7:54 PM
Ignite Modification Date:
2026-01-06 @ 6:32 AM
Study NCT ID:
NCT00596804
Status:
COMPLETED
Last Update Posted:
2021-08-18
First Post:
2008-01-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety Study of Different Doses of hA20 (Veltuzumab) in CD20+ Non-Hodgkin's Lymphoma
Sponsor:
Gilead Sciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-03
Start Date Type:
None
Primary Completion Date:
2007-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-11
Completion Date Type:
ACTUAL
First Submit Date:
2008-01-08
First Submit QC Date:
None
Study First Post Date:
2008-01-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-08-12
Last Update Post Date:
2021-08-18
Last Update Post Date Type:
ACTUAL